NUEVOLUTION A/S: Financial statements 2020
CVR: 26029708
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NUEVOLUTION A/S (CVR 26029708) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 37,024,000 and a net result of DKK -33,490,000 compared with DKK -76,305,000 the year before. That is an increase of 113.3% compared with the year before. The profit margin was -90.5%. Equity in the 2020 report amounted to DKK 69,479,000. The solvency ratio was 56.8%. The company had 54 employees in the financial year.
- Revenue
- DKK 37,024,000
- Profit/Loss
- DKK -33,490,000
- Equity
- DKK 69,479,000
- Total Assets
- DKK 122,370,000
- Employees
- 54
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 37 mio. | - | -33.5 mio. | 69.5 mio. | 54 |
| 2019 | 17.4 mio. | - | -76.3 mio. | 1.8 mio. | 49 |
| 2018 | 8.1 mio. | - | -64.3 mio. | 64.9 mio. | - |
| 2017 | 91.9 mio. | - | -16.5 mio. | 61.4 mio. | - |
| 2016 | 17 mio. | -37.4 mio. | -104.9 mio. | 15.6 mio. | - |
How creditworthy is NUEVOLUTION A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of December 23, 2020, Mads Torkild Hansen has left the board of directors of NUEVOLUTION A/S.
As of December 23, 2020, Johnny Stilou has stepped down as director of NUEVOLUTION A/S.
As of December 23, 2020, Thomas Franch has stepped down as director of NUEVOLUTION A/S.
As of December 23, 2020, Antonius Franciscus Berkien has stepped down as director of NUEVOLUTION A/S.
NUEVOLUTION A/S has published its annual report for 2019. Revenue came to DKK 17,360,000, and the net result was DKK -76,305,000.
About NUEVOLUTION A/S
NUEVOLUTION A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2001. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named CHEMGENE ApS. The management consists of Thomas Franch. The board consists of Tore von Würden Petersen (chair), Jeffrey David Bernd and Omari Clinton Wise. The company is owned by Amgen, Inc.. The company has 59 employees (2018). In 2025, the company reported revenue of DKK 203,323,000 and a net result of DKK 39,754,000 compared with DKK -18,383,000 the year before. Equity in the 2025 report amounted to DKK 89,493,000.